Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


23.04.2018

3 BMC Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
2 Oncol Rep
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. SEEBACHER V, Polterauer S, Reinthaller A, Koelbl H, et al
    AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.
    BMC Cancer. 2018;18:447.
    PubMed     Text format     Abstract available

  2. ZHU Y, Zhou S, Liu Y, Zhai L, et al
    Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
    BMC Cancer. 2018;18:443.
    PubMed     Text format     Abstract available

  3. TANG Z, Yang J, Wang X, Zeng M, et al
    Active DNA end processing in micronuclei of ovarian cancer cells.
    BMC Cancer. 2018;18:426.
    PubMed     Text format     Abstract available


    Cancer Lett

  4. LUO Q, Wu X, Zhang Y, Shu T, et al
    ARID1A ablation leads to Multiple Drug Resistance in ovarian cancer via transcriptional activation of MRP2.
    Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30274.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. DI LJ, Hao D, Liu J, Chen M, et al
    Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemo-sensitivity.
    Clin Cancer Res. 2018 Apr 16. pii: 1078-0432.CCR-17-3862.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  6. CAPOTE S, Sanchez-Iglesias JL, Cubo-Abert M, De la Torre J, et al
    Myeloid sarcoma as a simulator of advanced ovarian cancer: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2018 Mar 28. pii: S0301-2115(18)30154.
    PubMed     Text format    


    Oncol Rep

  7. GARCIA-VAZQUEZ R, Gallardo Rincon D, Ruiz-Garcia E, Meneses Garcia A, et al
    let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6366.
    PubMed     Text format     Abstract available

  8. CHEN Z, Zhu J, Zhu Y, Wang J, et al
    MicroRNA-616 promotes the progression of ovarian cancer by targeting TIMP2.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6368.
    PubMed     Text format     Abstract available


    PLoS One

  9. GSCHWANTLER-KAULICH D, Weingartshofer S, Rappaport-Furhauser C, Zeillinger R, et al
    Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
    PLoS One. 2018;13:e0196142.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: